These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8215267

  • 1. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.
    Gómez-Jiménez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, Martínez-Vázquez JM.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1587-92. PubMed ID: 8215267
    [Abstract] [Full Text] [Related]

  • 2. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I, Topcu N, Durmus A, Turkdogan MK.
    Hepatogastroenterology; 2003 Aug; 50(53):1426-30. PubMed ID: 14571754
    [Abstract] [Full Text] [Related]

  • 3. Five days of ceftriaxone to treat culture negative neutrocytic ascites in cirrhotic patients.
    Baskol M, Gursoy S, Baskol G, Ozbakir O, Guven K, Yucesoy M.
    J Clin Gastroenterol; 2003 Aug; 37(5):403-5. PubMed ID: 14564189
    [Abstract] [Full Text] [Related]

  • 4. Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients.
    França A, Giordano HM, Sevá-Pereira T, Soares EC.
    J Gastroenterol; 2002 Aug; 37(2):119-22. PubMed ID: 11871762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone.
    França AV, De Souza JB, Silva CM, Soares EC.
    J Clin Gastroenterol; 2001 Oct; 33(4):295-8. PubMed ID: 11588542
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis.
    Sánchez E, Francés R, Soriano G, Mirelis B, Sancho FJ, González-Navajas JM, Muñoz C, Song XY, Pérez-Mateo M, Such J, Guarner C.
    PLoS One; 2013 Dec; 8(3):e59692. PubMed ID: 23527251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in the patterns and microbiology of spontaneous bacterial peritonitis : analysis of 200 cirrhotic patients.
    Al-Ghamdi H, Al-Harbi N, Mokhtar H, Daffallah M, Memon Y, Aljumah AA, Sanai FM.
    Acta Gastroenterol Belg; 2019 Dec; 82(2):261-266. PubMed ID: 31314186
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Ardolino E, Wang SS, Patwardhan VR.
    Dig Dis Sci; 2019 Aug; 64(8):2359-2367. PubMed ID: 30761472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.